在复杂的电生理学程序期间,镇静相关结果的性别特异性差异
Lyuboslav Katov1, Weronika Huggle1, Yannick Teumer1
1Department of Cardiology, Ulm University Heart Center, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
这项研究发现,在电生理学手术期间,整体镇静并发症中没有显著的性别差异. 然而,女性体验到更多的氧气脱和血压降低,这表明需要针对性别的镇静剂调整.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 临床研究 临床研究
背景情况:
- 干预电生理学 (EPS) 需要深度镇静,以使患者舒适和不动.
- 镇静剂和止痛药可以导致呼吸抑制和低血压.
- 在镇静中,性别特异性差异 (GDs) 经常被忽视,这可能会影响女性的治疗安全性和疗效.
研究的目的:
- 为了检查二氧化碳水平,呼吸速率,动脉血压 (ABP) 和深度镇静期间对EPS的麻醉需求的性别特异性差异.
- 评估性别对接受EPS的患者与镇静相关并发症的影响.
主要方法:
- 702名患者 (405名男性,297名女性) 接受深度镇静治疗的前性研究.
- 标准监测包括心电图,非侵入性ABP,SpO2和静脉血液气体分析 (vBGA).
- 主要复合终点: SpO2 中的 GD 跌至 90% 以下,并出现病态的 vBGA 变化.
主要成果:
- 在女性 (59.6%) 和男性 (52.6%) (p=0.102) 的初级复合终点中没有显著差异.
- 女性具有显著更高的SpO2下降风险<90% (1.6倍,p=0.001),更高的缺氧率 (1.7倍,p<0.001) 和更低的平均ABP (1.5倍,p<0.001).
- 与男性相比,女性接受的普罗波少 (65.3毫克少,p=0.005) 和每公斤米达佐拉姆剂量更高 (p<0.001).
结论:
- 虽然主要复合终点没有显示出明显的性别差异,但次要结果表明需要针对女性进行性别特定的镇静调整.
- 在干预电生理学中,个性化镇静管理和考虑到性别特异性的患者监测至关重要.
更多相关视频
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
相关概念视频
Stages of General Anesthesia
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
